News Releases

September 25, 2025

MSD Animal Health Strengthens Its Dedication to Rabies Elimination with 7 Millionth Vaccine Donation Through the Afya Program

Rahway N.J., September 26, 2025 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced it has donated more than seven million NOBIVAC® rabies vaccines through the Company’s Afya Program, since it was founded. “Communities experiencing ongoing rabies outbreaks often lack essential resources and vaccines,” stated Ingrid Deuzeman, director of […]

September 27, 2024

MSD Animal Health Reaffirms its Commitment to Eliminating Rabies with its 6 Millionth Vaccine Donation Through the Afya Program

RAHWAY, N.J., August 29, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced it has donated more than six million NOBIVAC® rabies vaccines through the Company’s Afya Program, since it was founded. “Many communities where rabies outbreaks persist, have limited access to resources and vaccines,” said Ingrid Deuzeman, […]

March 18, 2024

MSD Animal Health Marks Commitment to Rabies Elimination Through Donation of NOBIVAC® Rabies Vaccines to Mission Rabies

Rahway, NJ., March 18, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK) has announced a continued commitment to rabies elimination through a donation of NOBIVAC® rabies vaccines to the Mission Rabies program, a charity initiative of the Worldwide Veterinary Service (WVS). The donations will continue over the […]